Navigation Links
Drexel researchers looking inside vessels to understand blood's ebb and flow
Date:9/4/2013

Researchers have known for some time that the blood vessels that transport blood to and from tissues and organs in the body are more than just bodily pipelines. Arterioles and capillaries, the small vessels, actually play a key role in regulating the flow of the blood they're carrying. Biomedical engineers at Drexel University, who study cardiovascular function, are creating a mathematical model that explains just how they do it.

The team, which includes Drs. Dov Jaron, Kenneth Barbee and Donald Buerk from Drexel's School of Biomedical Engineering, Science and Health Systems, will look specifically at mechanisms that govern the production of nitric oxide in the circulatory system. Nitric oxide is a chemical produced by endothelial cells that line the inner walls of blood vessels, which regulates blood pressure and flow by dilating the vessels. It also plays a role in the immune system's response to injuries and infections.

"This research is significant since the mechanisms that control the production of nitric oxide, and thereby control blood flow, are not fully known," Jaron said. "NIH is making it a priority to study this, since defects in nitric oxide in blood and tissues are known to lead to many diseases."

The National Heart, Lung and Blood Institute of The National Institutes of Health has pledged more than $3.3 million over five years to the Drexel team in hopes that its model could eventually play a role in combating one of the nation's leading killers: heart disease.

"This team is uniquely qualified to perform this research because it combines expertise in mathematical modeling and experiments," Barbee said. "We have identified novel mechanisms involved in the regulation of nitric oxide production that are not apparent using standard experimental approaches alone."

Using a flow chamber, invented at Drexel specifically for this type of research, the team will examine nitric oxide production in endothelial cells grown in the lab. While introducing chemical catalysts and inhibitors the team will be able to track in real time- how nitric oxide is produced. Adding this data on location and time factors involved in the production of nitric oxide will give Drexel's model another layer of depth and accuracy.

"In addition to the flow chamber technology, we also have the unique capability for using sensitive microelectrodes to measure nitric oxide in the microcirculation," Buerk said.

One thing that scientists already know about nitric oxide in the body is that the presence of high levels of cholesterol can block its production and thus contribute to the development of vascular disease. Drexel's model, which will be open-source, could help researchers in the field gain greater understanding of vascular function and test hypotheses about the biological pathways leading to the production of nitric oxide.


'/>"/>

Contact: Britt Faulstick
bef29@drexel.edu
215-895-2617
Drexel University
Source:Eurekalert

Related biology news :

1. Making memories: Drexel researchers explore the anatomy of recollection
2. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
3. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
4. Researchers attempt to solve problems of antibiotic resistance and bee deaths in one
5. UNH researchers find African farmers need better climate change data to improve farming practices
6. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
7. Researchers uncover molecular pathway through which common yeast becomes fungal pathogen
8. Researchers print live cells with a standard inkjet printer
9. Columbia Engineering and Penn researchers increase speed of single-molecule measurements
10. Researchers reveal how a single gene mutation leads to uncontrolled obesity
11. Researchers discover novel therapy for Crohns disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: